British Medical Journal (Clinical Research Ed.)
Fourth, the large sample sizes across the outcome cohorts provided adequate precision of effect estimates, and agent-specific analyses helped clarify whether associations were consistent across different GLP-1RA medications
Impact This study provides age- and sex-specific reference values for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon in children and adolescents
A better approach: Consider tracking your own progress by recording sleep quality, daily energy, exercise recovery, body measurements, weight (when appropriate), and other treatment goals discussed with your healthcare provider
No, GLP-1 medications are not controlled substances and do not appear on standard employment drug screenings, which test for substances of abuse like opioids, amphetamines, and cannabis